Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Plans Benlysta Expansion In Lupus Nephritis Based On Successful Phase III

Dec 18 2019

• By Jessica Merrill

GSK is expanding Benlysta in lupus • Source: Shutterstock

Related Content

AstraZeneca Closer To Filing Anifrolumab For Lupus

Nov 12 2019

Lupus Market Snapshot: There's No Debate It's A Blockbuster Opportunity

Aug 10 2017

Aurinia Closing In On Lupus Nephritis With Voclosporin

Dec 05 2019

Benlysta Is Niche, But Growing, So GSK's Not Giving Up On Lupus

Aug 07 2017

Related Companies

GSK plc

Human Genome Sciences, Inc.

Aurinia Pharmaceuticals Inc.

Roche Holding AG

AstraZeneca PLC

Biogen, Inc.

Additional Topics

Clinical Trials Commercial Immune Disorders BioPharmaceutical

More from Immunological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window